For years, the prevailing model has been simple: DNA damage → micronuclei → cGAS activation → inflammation. A new study in Nature Cell Biology challenges that framework with a powerful new tool that directly measures cGAMP production—the earliest and most specific readout of cGAS activation—at single-cell resolution. The authors engineered an improved FRET-based cGAMP reporter compatible with microscopy, flow cytometry, cell lysates, and biochemical assays. Unlike downstream markers such as IRF3, STAT1, or STING translocation, this biosensor reports the actual product synthesized by cGAS, providing a much more sensitive and direct measure of pathway activation. What they discovered was surprising. Across multiple forms of genotoxic stress—including ionizing radiation, doxorubicin, etoposide, PARP inhibition, and chromosome mis-segregation—only a small minority of cells (~10%) actually activated cGAS, and even those responses were relatively weak compared with direct DNA stimulation. Even more striking was what didn't correlate with activation. Although cGAS frequently accumulated on micronuclei, most micronuclei never generated cGAMP. Likewise, many cells producing cGAMP contained no micronuclei at all. These findings argue that simple cGAS localization to micronuclei is neither necessary nor sufficient for activation. Chromosome bridges told a more nuanced story. Following chromosome mis-segregation induced by MPS1 inhibition, cells that activated cGAS were much more likely to have experienced cGAS-positive chromosome bridges, whereas this relationship disappeared after ionizing radiation. Thus, chromosome bridges contribute only under specific forms of genomic instability rather than serving as a universal trigger. The study also revisits another controversial idea: DNA:RNA hybrids. Purified cGAS bound both DNA:RNA hybrids and R-loops with similar affinity, but binding alone did not predict signaling. Simple DNA:RNA hybrids were essentially inert. In contrast, R-loops, which contain more complex nucleic acid architecture, consistently activated cGAS both in cells and in biochemical reconstitution assays. This suggests that structural complexity—not simply hybrid composition—is what licenses cGAS activation. Another fascinating observation is that activated cells often formed local clusters. Rather than reflecting simultaneous activation, these clusters resulted from cGAMP transfer through gap junctions, allowing neighboring cells to become activated without producing cGAMP themselves. The inflammatory signal therefore spreads beyond the original sensing cell. The conceptual shift is important. Instead of a uniform tissue-wide response after DNA damage, cGAS activation appears to occur as rare, localized signaling hubs that subsequently amplify inflammation through intercellular cGAMP transfer. This may help explain why previous studies produced conflicting conclusions regarding micronuclei and cGAS biology. Beyond its biological insights, the paper introduces a versatile platform that should become widely useful for studying innate immunity, chromosomal instability, aging, radiotherapy responses, and cancer immunology with single-cell precision. Reference Lebrec V, Kanellou A, Davies LR, et al. A versatile cGAMP reporter reveals principles of cGAS activation by DNA damage and chromosome instability. Nature Cell Biology (2026). DOI: doi.org/10.1038/s41556-026-0…